ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

NRIX Nurix Therapeutics Inc

13,22
0,44 (3,44%)
06 Mai 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Nurix Therapeutics Inc NRIX NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,44 3,44% 13,22 20:13:37
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
12,81 12,77 13,51 13,22 12,78
mais cotações »

Notícias Recentes

Data Hora Fonte Título
16/04/202419:21GLOBENurix Therapeutics Announces Closing of Public Offering and..
12/04/202400:38GLOBENurix Therapeutics Announces Pricing of Upsized $175.0..
11/04/202417:00GLOBENurix Therapeutics Announces Proposed Public Offering
10/04/202408:00GLOBENurix Therapeutics Reports First Quarter Fiscal 2024..
09/04/202414:15GLOBENurix Therapeutics Reports First Clinical Evidence of CNS..
09/04/202408:00GLOBENurix Therapeutics Announces Extension of Strategic..
03/04/202408:00GLOBENurix Therapeutics to Participate in Upcoming Investor..
02/04/202408:00GLOBENurix Therapeutics Announces Extension of Strategic..
25/03/202408:00GLOBENurix Therapeutics is Part of a Team of International..
20/03/202410:40GLOBENurix Presents the Discovery and Chemical Structure of..
11/03/202408:00GLOBENurix Therapeutics Announces U.S. FDA Lifts Partial Clinical..
06/03/202418:00GLOBENurix Therapeutics to Participate in Upcoming Investor..
05/03/202418:30GLOBENurix Therapeutics Announces Presentations at the American..
15/02/202418:00GLOBENurix Therapeutics Reports Fourth Quarter and Fiscal Year..
01/02/202418:01GLOBENurix Therapeutics Announces Publication in the Journal..
16/01/202418:48DJNNurix Therapeutics Gets FDA Fast-Track Designation for..
16/01/202418:01GLOBENurix Therapeutics Receives U.S. FDA Fast Track Designation..
08/01/202409:00GLOBENurix Therapeutics Outlines 2024 Strategic Priorities with..
02/01/202418:01GLOBENurix Therapeutics to Present at 42nd Annual J.P. Morgan..
13/12/202318:32GLOBEJudith A. Reinsdorf and Katherine M. Sandstrom Named to Toll..
11/12/202314:00GLOBENurix Therapeutics Presents Positive Clinical Data from Its..
04/12/202318:01GLOBENurix Therapeutics Announces Webcast To Review Data from Its..
07/11/202318:01GLOBENurix Therapeutics to Participate in Upcoming Investor..
02/11/202310:00GLOBENurix Therapeutics Announces Presentations at the 65th..
01/11/202318:16DJNNurix Therapeutics Says FDA Places Partial Clinical Hold on..
01/11/202317:01GLOBENurix Therapeutics Announces Partial Clinical Hold For..
12/10/202317:01GLOBENurix Therapeutics Reports Third Quarter Fiscal 2023..
07/09/202308:00GLOBENurix Announces Strategic Collaboration with Seagen..
31/08/202317:01GLOBENurix Therapeutics to Participate in Upcoming Investor..
13/07/202317:01GLOBENurix Therapeutics Reports Second Quarter Fiscal 2023..
14/06/202308:00GLOBENurix Therapeutics Presents Data from Studies of Its..
09/05/202317:01GLOBENurix Therapeutics to Participate in the 2023 RBC Capital..

Seu Histórico Recente

Delayed Upgrade Clock